Furubayashi N, Morokuma F, Tomoda T, Hori Y, et al. Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study. Anticancer Res 2022;42:1571-1577.
PMID: 35220254